Biosensors Financials. Company Will Now Co-promote With Japanese Partner, Terumo.

Device company Biosensors International Group, Ltd., has announced financial results for its third fiscal quarter (“Q3 FY13”) and nine months ended 31 December 2012. In a newly announced arrangement the company will now co-promote its Nobori stent in Japan with Terumo, replacing the original distribution arrangement.



Biosensors Reports Financial Results for the Third Quarter of Fiscal Year 2013 (via PR Newswire)

SINGAPORE, Feb. 7, 2013 /PRNewswire/ — Biosensors International Group, Ltd. (“Biosensors” or the “Company”, Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its third fiscal quarter (“Q3 FY13…


published: February 7, 2013 in: Cardio, Financial

Most read

Latest

^